Detalles de la búsqueda
1.
Cost-effectiveness of idecabtagene vicleucel compared with conventional care in triple-class exposed relapsed/refractory multiple myeloma patients in Canada and France.
J Med Econ
; 26(1): 243-253, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36705644
2.
Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumab.
BMJ Open
; 13(5): e067516, 2023 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37192793
3.
Excess costs of multiple sclerosis: a register-based study in Sweden.
Eur J Health Econ
; 24(8): 1357-1371, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36418785
4.
Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries.
Mult Scler
; 18(2 Suppl): 7-15, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22623122
5.
Early vs. late treatment initiation in multiple sclerosis and its impact on cost of illness: A register-based prospective cohort study in Sweden.
Mult Scler J Exp Transl Clin
; 8(2): 20552173221092411, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35496759
6.
Observational study of the implementation of telephone advice nursing in Sweden: did callers follow recommendations and did the rate of healthcare visits change?
BMJ Open
; 11(8): e051233, 2021 08 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34413110
7.
Cost-of-Illness Progression Before and After Diagnosis of Multiple Sclerosis: A Nationwide Register-Based Cohort Study in Sweden of People Newly Diagnosed with Multiple Sclerosis and a Population-Based Matched Reference Group.
Pharmacoeconomics
; 39(7): 835-851, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33970446
8.
Productivity losses among people with back pain and among population-based references: a register-based study in Sweden.
BMJ Open
; 10(8): e036638, 2020 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32792439
9.
Diagnosis-specific sickness absence and disability pension before and after multiple sclerosis diagnosis: An 8-year nationwide longitudinal cohort study with matched references.
Mult Scler Relat Disord
; 42: 102077, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32353754
10.
Types of working-life sequences among people recently diagnosed with multiple sclerosis in Sweden: a nationwide register-based cohort study.
BMJ Open
; 10(12): e039228, 2020 12 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-33376161
11.
Cost-of-illness trajectories among people with multiple sclerosis by comorbidity: A register-based prospective study in Sweden.
Mult Scler J Exp Transl Clin
; 6(4): 2055217320968597, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33149932
12.
Healthcare, Sickness Absence, and Disability Pension Cost Trajectories in the First 5 Years After Diagnosis with Multiple Sclerosis: A Prospective Register-Based Cohort Study in Sweden.
Pharmacoecon Open
; 4(1): 91-103, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31187461
13.
Trajectories of disposable income among people of working ages diagnosed with multiple sclerosis: a nationwide register-based cohort study in Sweden 7 years before to 4 years after diagnosis with a population-based reference group.
BMJ Open
; 8(5): e020392, 2018 05 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29743325
14.
An indirect treatment comparison of efficacy and health-related quality of life following treatment with idecabtagene vicleucel versus belantamab mafodotin in triple-class exposed relapsed/refractory patients with multiple myeloma.
Leuk Lymphoma
; 64(11): 1864-1869, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37497883
15.
Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from the United Kingdom.
Mult Scler
; 18(2 Suppl): 41-5, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22623127
16.
Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from Germany.
Mult Scler
; 18(2 Suppl): 23-7, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22623124
17.
Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from Italy.
Mult Scler
; 18(2 Suppl): 29-34, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22623125
18.
Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from Spain.
Mult Scler
; 18(2 Suppl): 35-9, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22623126
19.
Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from France.
Mult Scler
; 18(2 Suppl): 17-22, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22623123
20.
Does a hospital admission in old age denote the beginning of life with a compromised health-related quality of life? A longitudinal study of men and women aged 65â years and above participating in the Stockholm Public Health Cohort.
BMJ Open
; 6(7): e010901, 2016 07 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27401358